The method of calculation of the MRSA bacteremia infection rate for the reporting period is:
Number of nosocomial patients with laboratory identification of MRSA bacteremia x 1000
Total number of patient days (for one month)
Where the numerator is the total number of newly identified cases for MRSA bacteremia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.
HGMH MRSA Rates
|Reporting Period||MRSA Rate per 1,000 Patient Days||Case Count|
|October - December 2017||0||0|
|July - September 2017||0||0|
|April - June 2017||0||0|
|January - March 2017||0||0|
|October - December 2016||0||0|
|July - September 2016||0||0|
|April - June 2016||0||0|
|January - March 2016||0||0|
|October - December 2015||0||0|
|July - September 2015||0||0|
|April - June 2015||0.44||1|
|January - March 2015||0||0|
|October - December 2014||0||0|
|July - September 2014||0||0|
|April - June 2014||0||0|
|January - March 2014||0||0|
|October - December 2013||0||0|
|July - September 2013||0||0|
|April - June 2013||0||0|
|January - March 2013||0||0|
|October - December 2012||0||0|
|July - September 2012||0||0|
|April - June 2012||0||0|
|January - March 2012||0||0|
|October - December 2011||0||0|
|July - September 2011||0||0|
|April - June 2011||0||0|
|January - March 2011||0||0|
|October - December 2010||0||0|
|July - September 2010||0||0|
|April - June 2010||0||0|
|January - March 2010||0||0|
|October - December 2009||0||0|
|July - September 2009||0||0|
|April - June 2009||0||0|
|September - November 2008||0||0|
Information for Patients and Families
Glengarry Memorial Hospital takes your care and your safety very seriously and we are extremely committed to transparency. On a quarterly basis, beginning in December, we will be reporting our infection rates on our website.
If you have any questions about the information below or about our hospital's infection prevention and control program please contact Infection Prevention and Control Practitioner Joann Beckstead, R.N., C.I.C. at 613-525-2222 ext .4114.
Measuring Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococci (VRE) rates.
Glengarry Memorial Hospital posts its infection rates online on a quarterly basis. On this website, you can find information about hospital-acquired infection rates for MRSA and VRE.
What does hospital acquired mean?
Sometimes when patients are admitted to the hospital, they can get infections. This is a hospital-acquired infection. In the case of either MRSA or VRE, this may mean that symptoms begin 72 hours after admission to the hospital; or that the infection was present at the time of admission but was related to a previous admission to that hospital within the last 4 weeks.
What is Methicillin-resistant Staphylococcus aureus (MRSA)?
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain or all types of the beta-lactam classes of antibiotics such as penicillins, penicillinase-resistant penicillins (e.g. cloxacillins and cephalosporins. MRSA are strains of S. aureus that have an MIC to oxacillin of greater than or equal to 4 mcg/ml. or contain the mecA gene coding for penicillin binding protein 2a (PBP 2a).
What are the risk factors for MRSA?
Risk factors for MRSA acquisition include invasive procedures, prior treatment with antibiotics, prolonged hospital stay, stay in an intensive care or burn unit, surgical wound infection and a close proximity to a colonized person. MRSA can also be transmitted from mother to child through breast milk.
How is MRSA transmitted?
The single most important mode of transmission of MRSA in a health care setting is via transiently colonized hands of health care workers who acquire it from contact with colonized or infected patients, or after handling contaminated material or equipment. The unrecognized colonized patient presents a particular risk for transmission to other patients.
How are MRSA and VRE diagnosed?
If you meet the criteria for the screening protocol, the nurse will take swabs of your nose and rectum and any broken areas of your skin. This testing allows us to find carriers quickly and prevent spread to other patients. The results will be reported to your physician.
How are MRSA and VRE treated?
Many bacteria live on and in the body without causing disease/infection. This is colonization. Colonization does not require treatment. These same bacteria under the right conditions can cause disease. This is infection. MRSA can colonize in the nose, the skin and the respiratory tract. It can cause infection in the respiratory tract, in surgical sites and in the blood. Treatment depends on how sick patients are with the disease.
What precautions are used to prevent the spread of both MRSA and VRE in the hospital?
If you are found to carry MRSA or VRE, you will be placed in a single room and put under special Infection Control precautions. This is to ensure that the germs cannot spread to other patients. Your medical care that you require will not be affected.
What Glengarry Memorial Hospital is doing to improve patient safety:
- Hand hygiene program with increased access to alcohol gel
- Screening patients on admission for silent carriage of resistant organisms
- Use of single rooms, (when possible) masks, gowns, and gloves to control transmission
- Increased housekeeping resources
- Education and awareness campaigns for patients and health care providers